Biogen Idec, Inc

Case [2011] APO 17


IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Biogen Idec Inc. [2011] APO 17

Patent Application:                   2008243164

Title:Recombinant antibodies coexpressed with GnTlll

Patent Applicant:  Biogen Idec Inc.

Delegate:  Dr S.D.Barker

Decision Date:  22 March 2011

Catchwords:  PATENTS – examiner objection – case management of divisional applications – no response by applicant – application refused

Representation:  Patent applicant:  Shelston IP

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:                   2008243164

Title:Recombinant antibodies coexpressed with GnTlll

Patent Applicant:  Biogen Idec Inc.

Date of Decision:  22 March 2011

DECISION

I refuse the application.

REASONS FOR DECISION

Patent application 2008243164 was filed by Biogen Idec Inc. as a divisional of application 2002307037 on 7 November 2008.  An examination report issued on 22 November 2010, raising seven objections.  In line with the Commissioner's approach to case management of divisionals, the report included the following note:

"Objections 1-5 of my report are based on the same grounds objected to in the examination of patent application 2002307037. Please note that if a response overcoming those objections is not filed within two months of the date of this report the Commissioner will consider whether to direct amendment of the application under section 107 or proceed to refuse the application under section 49(2) of the Act. If intending to proceed under either of these provisions the Commissioner will notify you in writing and indicate the time and place you may be heard on the matter. In deciding the matter the Commissioner will consider all possible grounds of objection to the application not only those identified above."

As no reply was received, the Commissioner issued a hearing notice in the following terms:

"The examination report of 22 November 2010 raised an objection(s) equivalent to that in the parent application. In line with our approach to case management of divisionals, you were given two months to respond to that report. As no response has been received, the matter will now be set for hearing.

I believe that it is possible to hear this matter on the basis of written submissions, so I allow you one (1) month from the date of this letter to file any submissions you wish. Your submissions should address the ground(s) of objection identified in the examination report. Once your submissions have been received, or alternatively if no submissions are received, the matter will be passed to a hearing officer to issue a written decision. Please note that it is possible for the Commissioner to refuse the application or direct amendment.

Alternatively, if you file amendments overcoming the objection(s) within this period, the Commissioner will not proceed with the hearing. However, if the amendments do not fully overcome the objection(s), you will be advised of this fact and the hearing may continue as above."

The applicant has not provided any submissions.

The objection

I have reviewed the examiner's report, and I agree that there are appropriately raised objections.  The applicant has chosen not to defend the application.  They have provided no submissions disputing the objections, and have not proposed any amendment to attempt to overcome the objections.  In these circumstances there are no reasonable prospects of the applicant overcoming the objections.  The application should be refused.

Dr S.D.Barker
Delegate of the Commissioner of Patents

Details
AGLC
Biogen Idec, Inc [2011] APO 17
Case
[2011] APO 17
Decision Date

CaseChat Overview and Summary

Biogen Idec Inc. has applied for patent protection over recombinant antibodies coexpressed with GnTlll. The application was filed as a divisional of application 2002307037, and the application number is 2008243164. The applicant did not respond to an examination report, which raised several objections, leading to a refusal of the application by Dr. S.D. Barker, the delegate of the Commissioner of Patents. The applicant was represented by Shelston IP.

The legal issues that the court was required to decide included whether the objections raised in the examination report were appropriately raised, and whether the applicant had any reasonable prospects of overcoming those objections. The court had to consider the Commissioner's approach to case management of divisional applications, as well as the applicant's failure to respond to the examination report or propose any amendments.

The court found that the objections raised in the examination report were appropriately raised, and that the applicant had not provided any submissions disputing the objections or proposing any amendments. The court noted that in these circumstances, there were no reasonable prospects of the applicant overcoming the objections. The court agreed with the delegate's decision to refuse the application.

The court's decision was based on the applicant's failure to respond to the examination report or propose any amendments to overcome the objections. The court found that the objections raised in the examination report were appropriately raised, and that the applicant had not provided any submissions disputing the objections or proposing any amendments. The court concluded that in these circumstances, there were no reasonable prospects of the applicant overcoming the objections, and the application should be refused.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.